These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 31778083)

  • 21. The construct validity, responsiveness, reliability and interpretability of the Recap of atopic eczema questionnaire (RECAP) in children.
    Ragamin A; Zhang J; Pasmans SGMA; Schappin R; Romeijn GLE; van Reusel MA; Oosterhaven JAF; Schuttelaar MLA
    Br J Dermatol; 2024 May; 190(6):867-875. PubMed ID: 38262143
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Atopic Dermatitis Burden Scale for Adults: Development and Validation of a New Assessment Tool.
    Taïeb A; Boralevi F; Seneschal J; Merhand S; Georgescu V; Taieb C; Ezzedine K
    Acta Derm Venereol; 2015 Jul; 95(6):700-5. PubMed ID: 25118699
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Atopic dermatitis burden scale: creation of a specific burden questionnaire for families.
    Méni C; Bodemer C; Toulon A; Merhand S; Perez-Cullell N; Branchoux S; Taieb C
    J Eur Acad Dermatol Venereol; 2013 Nov; 27(11):1426-32. PubMed ID: 23675975
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development and validation of a questionnaire to measure empowerment in adult patients with atopic dermatitis. The DATEMP questionnaire.
    Pereyra-Rodriguez JJ; Dominguez-Cruz JJ; Hernandez-Montoya C; Galan-Gutiérrez M; Carrasco PM; Luna SA; Navarro-Triviño FJ; Del Pozo J; Ruiz-Villaverde R
    J Dtsch Dermatol Ges; 2019 Sep; 17(9):923-931. PubMed ID: 31487109
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Validity and reliability of Patient-Reported Outcomes Measurement Information System Global Health scale in adults with atopic dermatitis.
    Schwartzman G; Lei D; Yousaf M; Janmohamed SR; Vakharia PP; Chopra R; Chavda R; Gabriel S; Patel KR; Singam V; Kantor R; Hsu DY; Silverberg JI
    J Am Acad Dermatol; 2021 Sep; 85(3):636-644. PubMed ID: 33484762
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development and initial validation of a Traditional Chinese Medicine symptom-specific outcome measure: a Zheng-related atopic dermatitis symptom questionnaire (ZRADSQ).
    Wu D; Huang C; Mo X; Liu J; Cai J; Liu C; Zhu H; Li H; Chen D
    Health Qual Life Outcomes; 2013 Dec; 11():212. PubMed ID: 24359229
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validation and Interpretation of Short Form 12 and Comparison with Dermatology Life Quality Index in Atopic Dermatitis in Adults.
    Silverberg JI; Gelfand JM; Margolis DJ; Boguniewicz M; Fonacier L; Grayson MH; Ong PY; Chiesa Fuxench ZC; Simpson EL
    J Invest Dermatol; 2019 Oct; 139(10):2090-2097.e3. PubMed ID: 31009616
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spanish Version of the RECAP Questionnaire to Assess Control of Atopic Eczema: Translation, Cultural Adaptation, Validation, and Correlations with Other Patient-Reported Outcome Measures.
    Onteniente-Gomis MM; Ortiz-Romero PL; Tous Romero F; Salamanca Castro AB; Ortiz de Frutos FJ
    Actas Dermosifiliogr; 2023 Jun; 114(6):488-493. PubMed ID: 36935038
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patient-reported burden in adults with atopic dermatitis: an international qualitative study.
    Wollenberg A; Gooderham M; Katoh N; Aoki V; Pink AE; Binamer Y; Silverberg JI
    Arch Dermatol Res; 2024 Jun; 316(7):380. PubMed ID: 38850461
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Italian validation of the Childhood Atopic Dermatitis Impact Scale: a contribution to its clinical application.
    Neri E; Agostini F; Gremigni P; Gobbi F; Casu G; Chamlin SL; Monti F
    J Invest Dermatol; 2012 Nov; 132(11):2534-43. PubMed ID: 22696057
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Psychometric Evaluation of a Novel Instrument Assessing the Impact of Migraine on Physical Functioning: The Migraine Physical Function Impact Diary.
    Kawata AK; Hsieh R; Bender R; Shaffer S; Revicki DA; Bayliss M; Buse DC; Desai P; Sapra S; Ortmeier B; Hareendran A
    Headache; 2017 Oct; 57(9):1385-1398. PubMed ID: 28857154
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reliability and validity of the Arabic version of "dermatitis family impact" questionnaire in children with atopic dermatitis.
    Al Robaee AA
    Int J Dermatol; 2010 Sep; 49(9):1063-7. PubMed ID: 20883272
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Psychometric validation of the Coronary Revascularisation Outcome Questionnaire (CROQv2) in the context of the NHS Coronary Revascularisation PROMs Pilot.
    Schroter S; Miles R; Green S; Jackson M
    BMJ Open; 2017 Feb; 7(2):e015915. PubMed ID: 28246146
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Measuring long-term disease control in patients with atopic dermatitis: A validation study of well-controlled weeks.
    Langan SM; Stuart B; Bradshaw L; Schmitt J; Williams HC; Thomas KS
    J Allergy Clin Immunol; 2017 Dec; 140(6):1580-1586. PubMed ID: 28456619
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Translation and validation of Portuguese of a questionnaire for evaluation of psychosomatic symptoms in adults with atopic dermatitis.
    Boleira M; Lupi O; Pires GV; Dias G; Seba AJ; Guimarães DB
    An Bras Dermatol; 2014; 89(5):763-9. PubMed ID: 25184916
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Child behaviour problems and childhood illness: development of the Eczema Behaviour Checklist.
    Mitchell AE; Morawska A; Fraser JA; Sillar K
    Child Care Health Dev; 2017 Jan; 43(1):67-74. PubMed ID: 27696503
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development and validation of Gaucher disease type 1 (GD1)-specific patient-reported outcome measures (PROMs) for clinical monitoring and for clinical trials.
    Elstein D; Belmatoug N; Deegan P; Göker-Alpan Ö; Hughes DA; Schwartz IVD; Weinreb N; Bonner N; Panter C; Fountain D; Lenny A; Longworth L; Miller R; Shah K; Schenk J; Sen R; Zimran A
    Orphanet J Rare Dis; 2022 Jan; 17(1):9. PubMed ID: 34991656
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Eczema control and treatment satisfaction in atopic dermatitis patients treated with dupilumab - a cross-sectional study from the BioDay registry.
    Oosterhaven JAF; Spekhorst LS; Zhang J; Voorberg AN; Romeijn GLE; Boesjes CM; de Graaf M; de Bruin-Weller MS; Schuttelaar MLA
    J Dermatolog Treat; 2022 Jun; 33(4):1986-1989. PubMed ID: 34151695
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Psychometric validation of the Hand Disability in Systemic Sclerosis-Digital Ulcers (HDISS-DU®) patient-reported outcome instrument.
    Mouthon L; Poiraudeau S; Vernon M; Papadakis K; Perchenet L; Khanna D
    Arthritis Res Ther; 2020 Jan; 22(1):3. PubMed ID: 31907061
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quality of life in infants and children with atopic dermatitis: addressing issues of differential item functioning across countries in multinational clinical trials.
    McKenna SP; Doward LC; Meads DM; Tennant A; Lawton G; Grueger J
    Health Qual Life Outcomes; 2007 Jul; 5():45. PubMed ID: 17662129
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.